Microwaves Ablation of Varicose Veins
1 other identifier
interventional
20
1 country
1
Brief Summary
Lower-limb varicose veins (VVs) are the most common of vascular diseases and affect up to one-third of the population, severely affecting the quality of life (QoL) of patients. In past decades, traditional surgical ligation and stripping were the gold standard therapy for patients with VVs; however, traditional methods have demonstrated high complication and recurrence rates. Thus, the practices are moving toward minimally invasive alternatives.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 22, 2021
CompletedFirst Posted
Study publicly available on registry
August 19, 2022
CompletedStudy Start
First participant enrolled
November 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2023
CompletedJuly 30, 2024
July 1, 2024
12 months
October 22, 2021
July 29, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
1.Number of Participants with Lack of flow or closed great saphenous vein
Complete ablation of varicose veins done or if any residual remind
6 months
2.Operation time
The time of the whole procedure
Intraoperative
Secondary Outcomes (2)
1. Number of Participants with recurrence varicose vein varicose veins reappear again after the operation
12 month
2. Number of Participants with adverse effect of the procedure
12 months
Study Arms (1)
Varicose veins
OTHERAblation of varicose veins by microwaves
Interventions
Microwave ablation is an endovenous treatment. This is a similar treatment approach as laser ablation and radiofrequency ablation. "Endovenous" means that the treatment device is inside the vein during treatment.
Eligibility Criteria
You may qualify if:
- Age between 18 and 60 years, either sex, elective admission
- primary symptomatic VVS (CEAP,C3-C6)
- Recurrent Varicose Veins after surgery
- Greater saphenous vein diameter up to 3 cm
- Greater saphenous vein with variable depth even with depth less than 6mm
- Greater saphenous vein with tortuosity
- Diabetic patient with risk of wound infection after surgery
- Patient with hostile groin
- Availability of patients for all follow-up visits
You may not qualify if:
- secondary Varicose Veins
- Acute thrombosis near the Saphenous-femoral junction
- Recanalized Greater saphenous vein
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Asyut University Hospitals, Faculty of Medicine, Department of Vascular Surgery .Timeframe of the study: 2 years
Asyut, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Mohamed Gamal glal, Lecturer
Lecturer at Vascular and endovascular surgery department Assuit University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
October 22, 2021
First Posted
August 19, 2022
Study Start
November 1, 2022
Primary Completion
October 31, 2023
Study Completion
December 15, 2023
Last Updated
July 30, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share